These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35413176)

  • 1. Understanding the Inhibitory and Antioxidant Effects of Pyrroloquinoline Quinone (PQQ) on Copper(II)-Induced α-Synuclein-119 Aggregation.
    Li S; Raja A; Noroozifar M; Kerman K
    ACS Chem Neurosci; 2022 Apr; 13(8):1178-1186. PubMed ID: 35413176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical flow injection analysis of the interaction between pyrroloquinoline quinone (PQQ) and α-synuclein peptides related to Parkinson's disease.
    Li S; Noroozifar M; Zhou J; Kerman K
    Analyst; 2021 Jul; 146(14):4545-4556. PubMed ID: 34251376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein.
    Kobayashi M; Kim J; Kobayashi N; Han S; Nakamura C; Ikebukuro K; Sode K
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1139-44. PubMed ID: 16962995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
    Teng Y; Zhao J; Ding L; Ding Y; Zhou P
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of ERK1/2 pathway in neuroprotective effects of pyrroloquinoline quinine against rotenone-induced SH-SY5Y cell injury.
    Zhang Q; Zhang J; Jiang C; Qin J; Ke K; Ding F
    Neuroscience; 2014 Jun; 270():183-91. PubMed ID: 24755484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease.
    Zhang Q; Chen S; Yu S; Qin J; Zhang J; Cheng Q; Ke K; Ding F
    Neuropharmacology; 2016 Sep; 108():238-51. PubMed ID: 27108097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease.
    Qin J; Wu M; Yu S; Gao X; Zhang J; Dong X; Ji J; Zhang Y; Zhou L; Zhang Q; Ding F
    Toxicol Lett; 2015 Nov; 238(3):70-82. PubMed ID: 26276080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemical Detection of Interaction between Copper(II) and Peptides Related to Pathological α-Synuclein Mutants.
    Li S; Kerman K
    Anal Chem; 2019 Mar; 91(6):3818-3826. PubMed ID: 30777422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy.
    Zhang Q; Zhou J; Shen M; Xu H; Yu S; Cheng Q; Ding F
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32977419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esterification of PQQ Enhances Blood-Brain Barrier Permeability and Inhibitory Activity against Amyloidogenic Protein Fibril Formation.
    Tsukakoshi K; Yoshida W; Kobayashi M; Kobayashi N; Kim J; Kaku T; Iguchi T; Nagasawa K; Asano R; Ikebukuro K; Sode K
    ACS Chem Neurosci; 2018 Dec; 9(12):2898-2903. PubMed ID: 30074759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane insertion exacerbates the α-Synuclein-Cu(II) dopamine oxidase activity: Metallothionein-3 targets and silences all α-synuclein-Cu(II) complexes.
    Calvo JS; Mulpuri NV; Dao A; Qazi NK; Meloni G
    Free Radic Biol Med; 2020 Oct; 158():149-161. PubMed ID: 32712192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
    Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q
    Front Immunol; 2021; 12():794770. PubMed ID: 34925379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.
    Jansen van Rensburg Z; Abrahams S; Bardien S; Kenyon C
    Mol Neurobiol; 2021 Nov; 58(11):5920-5936. PubMed ID: 34426907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity.
    Hara H; Hiramatsu H; Adachi T
    Neurochem Res; 2007 Mar; 32(3):489-95. PubMed ID: 17268846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy.
    Ardah MT; Eid N; Kitada T; Haque ME
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease.
    Sivakumar P; Nagashanmugam KB; Priyatharshni S; Lavanya R; Prabhu N; Ponnusamy S
    Neurochem Int; 2023 Jan; 162():105461. PubMed ID: 36460239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson's disease model via AMPK activation.
    Cheng Q; Chen J; Guo H; Lu JL; Zhou J; Guo XY; Shi Y; Zhang Y; Yu S; Zhang Q; Ding F
    Acta Pharmacol Sin; 2021 May; 42(5):665-678. PubMed ID: 32860006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant activity of calycosin against α-synuclein amyloid fibrils-induced oxidative stress in neural-like cells as a model of preventive care studies in Parkinson's disease.
    Pan Q; Ban Y; Khan S
    Int J Biol Macromol; 2021 Jul; 182():91-97. PubMed ID: 33798579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.